Specifically, miR-181b was activated in response to TGF-β signaling in hepatocellular carcinoma cells, and siRNA knockdown of Smad4 resulted in a decrease in mature miR-181b levels [63]. The gene discussed is TGFB1; the disease is hepatocellular carcinoma.